PATENT CLAIM ANALYSIS

Application Number: 15916388
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "250000"]

Abstract:
Disclosed herein are methods and compositions for the treatment of metabolic related disorders. The methods and compositions may be useful for improving systemic glucose metabolism in the liver on an individual in need thereof, via administration of administering a therapeutically effective amount of an agent that interferes with Ago2 activity and/or function in combination with a pharmaceutically acceptable excipient.

Claim (Index 3):
The method of  claim 1 , wherein said metabolic disorder is fatty liver disease.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.26531
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14778379', '14898033', '15753461', '14389722', '15117155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7293046557597574
- 35 USC 102 Novelty (BERT): 0.4981929600588858
- Combined Prediction Score: 0.7061934861896704
- Mean Citation Score: 210.7139
- Max Citation Score: 222.09145
- Similarity Product: 167.24911025547982

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test